|Articles|April 24, 2017
Novotech Signs MOU with South Korean Medical Center
Novotech announced that it has signed a Memorandum of Understanding (MOU) with South Korean medical institution, The Asan Medical Center.
Advertisement
Novotech announced that it has signed a Memorandum of Understanding (MOU) with South Korean medical institution, The Asan Medical Center (AMC). Under the agreement, the AMC will provide clinical trial advice while Novatech will assist in promoting the clinical research capabilities of the AMC internationally.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
How the NIMBLE Study Supported Adherence With Quarterly Dosing of CemdisiranSeptember 18th 2025
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
IQVIA and Veeva Join Forces to Improve Efficiency and Patient OutcomesSeptember 17th 2025
Managing Background Therapies in the NIMBLE Phase III TrialSeptember 17th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
2
Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success
3
Enhancing Clinical Trial Data Accuracy Through the IQVIA and Veeva Partnership
4
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
